Related references
Note: Only part of the references are listed.Disease-modifying effect of ASP3258, a novel phosphodiesterase type 4 inhibitor, on subchronic cigarette smoke exposure-induced lung injury in guinea pigs
Satoshi Kubo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Roflumilast
Leonardo M. Fabbri et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
JNK activation is responsible for mucus overproduction in smoke inhalation injury
Won-Il Choi et al.
RESPIRATORY RESEARCH (2010)
Quantitative Profiling Method for Oxylipin Metabolome by Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry
Jun Yang et al.
ANALYTICAL CHEMISTRY (2009)
The role of animal models in the pharmacological evaluation of emerging anti-inflammatory agents for the treatment of COPD
J. Craig Fox et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Development and characterization of a rat model of chronic obstructive pulmonary disease (COPD) induced by sidestream cigarette smoke
Hongao Zheng et al.
TOXICOLOGY LETTERS (2009)
Characterisation of the proximal airway squamous metaplasia induced by chronic tobacco smoke exposure in spontaneously hypertensive rats
Sarah J. Bolton et al.
RESPIRATORY RESEARCH (2009)
EET displays anti-inflammatory effects in TNF-α-stimulated human bronchi
Caroline Morin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response
Benjamin Keserue et al.
FASEB JOURNAL (2008)
NF-κB inhibition is involved in tobacco smoke-induced apoptosis in the lungs of rats
Cai-Yun Zhong et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Action of epoxyeicosatrienoic acids on cellular function
Arthur A. Spector et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs)
Bora Inceoglu et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors
Danyan Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain
Bora Inceoglu et al.
LIFE SCIENCES (2006)
Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors
Kara R. Schmelzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling
P Pokreisz et al.
HYPERTENSION (2006)
Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease
NC Barnes et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Cilomilast for COPD - Results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4
SI Rennard et al.
CHEST (2006)
Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension
O Jung et al.
HYPERTENSION (2005)
Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE
WS Powell et al.
PROGRESS IN LIPID RESEARCH (2005)
Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor
KR Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells
M Mata et al.
THORAX (2005)
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease
BR Celli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Tobacco smoke control of mucin production in lung cells requires oxygen radicals AP-1 and JNK
E Gensch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages
BG Cosio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Expression of ErbB receptors and mucins in the airways of long term current smokers
RA O'Donnell et al.
THORAX (2004)
The nature of small-airway obstruction in chronic obstructive pulmonary disease
JC Hogg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium
PR Burgel et al.
THORAX (2004)
The development of emphysema in cigarette smoke-exposed mice is strain dependent
A Guerassimov et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Chronic obstructive pulmonary disease: molecular and cellular mechanisms
PJ Barnes et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Systemic effects of chronic obstructive pulmonary disease
AGN Agustí et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Novel therapies for the treatment of inflammatory airway disease
DJ Hele et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2003)
Inhibition of tobacco smoke-induced lung inflammation by a catalytic antioxidant
KR Smith et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Cellular and structural bases of chronic obstructive pulmonary disease
M Saetta et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Comparison of PDE 4 inhibitors, rolipram and SB 207499 (Ariflo (TM), in a rat model of pulmonary neutrophilia
J Spond et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2001)
Share Paper
